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Patient-centredness versus achieving public health targets: A challenge for tuberculosis 
control 
 
Fulfilling its aims, the paper by de Kok et al. (2018) illuminates complexities in delivering 
anti-retroviral therapy adherence support to HIV/AIDS patients. A key study finding about 
tensions between patient-centredness, trust, and performance targets resonates with our 
work on tuberculosis (TB). Like HIV, this is a potentially lethal infectious disease for which 
adherence to treatment is a critical challenge. While de Kok et al focus on adherence 
support delivered in clinical encounters between patients and health professionals (micro 
level) we highlight here issues with conflicting priorities operating at the policy (macro) 
level. Specifically, we reflect on years of policy research and informal discussions with TB 
policymakers in Asian low and middle-income countries (LMICs), which reveal ongoing 
struggles to achieve funders’ performance targets while attaining equitable health gains for 
their populations (Khan & Coker, 2014).  
 
The Global Fund to Fight AIDS, Tuberculosis and Malaria - a major source of financing for 
national TB control programmes in LMICs - provides ‘performance-based funding’, which 
means that continued financial support is dependent on meeting pre-determined targets, 
including for TB treatment adherence and completion (The Global Fun, n.d.). When TB 
control programmes are considering expansion of TB services to under-served populations, 
such as those living in rural areas and conflict zones, policymakers are faced a difficult 
decision: do they prioritise unmet health needs and take on the risk that service delivery to 
hard to reach populations could jeopardise ‘performance’ against targets, and future 
funding? Our research team observed this situation in Myanmar in 2015, when drug-
resistant TB treatment was only available in one third of the country; there were clear 
tensions between the push to scale-up access to treatment, the lack of infrastructure to 
support scale-up in under-served areas, and the need to meet performance targets to 
secure future funding (The Global Fund, 2017; Khan et al 2017). 
 
Ambitious goals and catchy branding are ingredients that allow a health issue to mobilise 
people and resources and ascend the public policy agenda, as a seminar paper in this journal 
documented over 15 years ago (Ogden, et al., 2003). This strategy has been adopted by Zero 
TB Cities, which is a new initiative focused on a bold target: to create ‘islands of elimination’ 
in selected cities in LMICs. A human rights angle was adopted to support the rationale for 
Zero TB Cities, on the basis that LMIC populations should have a ‘access to the high standard 
of TB care that has been available for decades in Western Europe and North America’ (Zero 
TB Cities; Nicholson, Admay, Shakow, & Keshavjee, 2016).  While this initiative appears to 
have had initial success in attracting political attention and resources, we are concerned 
that pouring resources into eliminating TB from defined urban areas is likely to magnify 
urban-rural inequalities in target countries.  
 
In closing we would like to congratulate de Kok et al. for shedding light on an important, but 
poorly addressed, issue for HIV/AIDS control, and suggest that their findings are relevant 
more broadly. For us, this paper emphasised that when global health is framed in terms of a 
race to meet targets, it begins to shape the way we view long-term solutions to pressing 
health problems. We may start to believe that those who do not adhere to treatment, in the 
rural areas, in the migrant camps, put everyone else at risk. We may stop questioning why 
certain approaches to treatment do not work for some population groups. In an era when 
public health targets are becoming more prominent, we may benefit from remembering 
that not everything that can be counted counts and not everything that counts can be 
counted. 
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